General Information of Drug Off-Target (DOT) (ID: OTB2IHCT)

DOT Name Mitochondrial intermediate peptidase (MIPEP)
Synonyms MIP; EC 3.4.24.59
Gene Name MIPEP
Related Disease
Advanced cancer ( )
Cardiac arrest ( )
Cardiomyopathy ( )
Dilated cardiomyopathy ( )
Left ventricular noncompaction ( )
Lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome ( )
Lung cancer ( )
Lung carcinoma ( )
Mitochondrial disease ( )
Sickle-cell anaemia ( )
UniProt ID
MIPEP_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
EC Number
3.4.24.59
Pfam ID
PF01432
Sequence
MLCVGRLGGLGARAAALPPRRAGRGSLEAGIRARRVSTSWSPVGAAFNVKPQGSRLDLFG
ERRGLFGVPELSAPEGFHIAQEKALRKTELLVDRACSTPPGPQTVLIFDELSDSLCRVAD
LADFVKIAHPEPAFREAAEEACRSIGTMVEKLNTNVDLYQSLQKLLADKKLVDSLDPETR
RVAELFMFDFEISGIHLDKEKRKRAVDLNVKILDLSSTFLMGTNFPNKIEKHLLPEHIRR
NFTSAGDHIIIDGLHAESPDDLVREAAYKIFLYPNAGQLKCLEELLSSRDLLAKLVGYST
FSHRALQGTIAKNPETVMQFLEKLSDKLSERTLKDFEMIRGMKMKLNPQNSEVMPWDPPY
YSGVIRAERYNIEPSLYCPFFSLGACMEGLNILLNRLLGISLYAEQPAKGEVWSEDVRKL
AVVHESEGLLGYIYCDFFQRADKPHQDCHFTIRGGRLKEDGDYQLPVVVLMLNLPRSSRS
SPTLLTPSMMENLFHEMGHAMHSMLGRTRYQHVTGTRCPTDFAEVPSILMEYFANDYRVV
NQFARHYQTGQPLPKNMVSRLCESKKVCAAADMQLQVFYATLDQIYHGKHPLRNSTTDIL
KETQEKFYGLPYVPNTAWQLRFSHLVGYGARYYSYLMSRAVASMVWKECFLQDPFNRAAG
ERYRREMLAHGGGREPMLMVEGMLQKCPSVDDFVSALVSDLDLDFETFLMDSE
Function Cleaves proteins, imported into the mitochondrion, to their mature size.

Molecular Interaction Atlas (MIA) of This DOT

10 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Advanced cancer DISAT1Z9 Strong Biomarker [1]
Cardiac arrest DIS9DIA4 Strong Genetic Variation [2]
Cardiomyopathy DISUPZRG Strong CausalMutation [3]
Dilated cardiomyopathy DISX608J Strong CausalMutation [3]
Left ventricular noncompaction DISJ4QEG Strong CausalMutation [3]
Lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome DISC92JF Strong Autosomal recessive [3]
Lung cancer DISCM4YA Strong Genetic Variation [4]
Lung carcinoma DISTR26C Strong Genetic Variation [4]
Mitochondrial disease DISKAHA3 Moderate Autosomal recessive [5]
Sickle-cell anaemia DIS5YNZB Limited Genetic Variation [6]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the methylation of Mitochondrial intermediate peptidase (MIPEP). [7]
------------------------------------------------------------------------------------
10 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Ciclosporin DMAZJFX Approved Ciclosporin decreases the expression of Mitochondrial intermediate peptidase (MIPEP). [8]
Tretinoin DM49DUI Approved Tretinoin decreases the expression of Mitochondrial intermediate peptidase (MIPEP). [9]
Acetaminophen DMUIE76 Approved Acetaminophen increases the expression of Mitochondrial intermediate peptidase (MIPEP). [10]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate affects the expression of Mitochondrial intermediate peptidase (MIPEP). [11]
Ivermectin DMDBX5F Approved Ivermectin decreases the expression of Mitochondrial intermediate peptidase (MIPEP). [12]
Vorinostat DMWMPD4 Approved Vorinostat increases the expression of Mitochondrial intermediate peptidase (MIPEP). [13]
Testosterone DM7HUNW Approved Testosterone increases the expression of Mitochondrial intermediate peptidase (MIPEP). [14]
Urethane DM7NSI0 Phase 4 Urethane decreases the expression of Mitochondrial intermediate peptidase (MIPEP). [15]
Fenretinide DMRD5SP Phase 3 Fenretinide affects the expression of Mitochondrial intermediate peptidase (MIPEP). [16]
Formaldehyde DM7Q6M0 Investigative Formaldehyde decreases the expression of Mitochondrial intermediate peptidase (MIPEP). [17]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Drug(s)

References

1 ncRNA-Encoded Peptides or Proteins and Cancer.Mol Ther. 2019 Oct 2;27(10):1718-1725. doi: 10.1016/j.ymthe.2019.09.001. Epub 2019 Sep 6.
2 The role of BCL11A and HMIP-2 polymorphisms on endogenous and hydroxyurea induced levels of fetal hemoglobin in sickle cell anemia patients from southern Brazil.Blood Cells Mol Dis. 2016 Nov;62:32-37. doi: 10.1016/j.bcmd.2016.11.002. Epub 2016 Nov 9.
3 MIPEP recessive variants cause a syndrome of left ventricular non-compaction, hypotonia, and infantile death. Genome Med. 2016 Nov 1;8(1):106. doi: 10.1186/s13073-016-0360-6.
4 A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese.Nat Genet. 2011 Jul 3;43(8):792-6. doi: 10.1038/ng.875.
5 Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2020 Feb;22(2):245-257. doi: 10.1038/s41436-019-0686-8. Epub 2019 Nov 6.
6 The association of HBG2, BCL11A, and HMIP polymorphisms with fetal hemoglobin and clinical phenotype in Iraqi Kurds with sickle cell disease.Int J Lab Hematol. 2019 Feb;41(1):87-93. doi: 10.1111/ijlh.12927. Epub 2018 Sep 14.
7 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
8 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
9 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423. doi: 10.3390/cells9112423.
10 Increased mitochondrial ROS formation by acetaminophen in human hepatic cells is associated with gene expression changes suggesting disruption of the mitochondrial electron transport chain. Toxicol Lett. 2015 Apr 16;234(2):139-50.
11 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
12 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
13 Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests. Arch Toxicol. 2017 Feb;91(2):839-864.
14 The exosome-like vesicles derived from androgen exposed-prostate stromal cells promote epithelial cells proliferation and epithelial-mesenchymal transition. Toxicol Appl Pharmacol. 2021 Jan 15;411:115384. doi: 10.1016/j.taap.2020.115384. Epub 2020 Dec 25.
15 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
16 4-HPR modulates gene expression in ovarian cells. Int J Cancer. 2006 Sep 1;119(5):1005-13. doi: 10.1002/ijc.21797.
17 Characterization of formaldehyde's genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol. 2013 Nov;87(11):1999-2012.